NCT04782986

Brief Summary

The authors hypothesize that in patients with iron deficiency anemia or gastrointestinal bleeding, pan-intestinal capsule endoscopy is a safe and well tolerated procedure that may improve diagnostic yield comparatively to the current standard invasive colonoscopy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 19, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 20, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 4, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
Last Updated

September 22, 2023

Status Verified

September 1, 2023

Enrollment Period

2.3 years

First QC Date

February 20, 2021

Last Update Submit

September 21, 2023

Conditions

Keywords

iron deficiency anemiagastrointestinal bleedingpan-intestinal capsule endoscopy

Outcome Measures

Primary Outcomes (1)

  • Number of participants with at least one potentially bleeding lesion detected in small bowel and/or colon

    Potentially bleeding lesions include tumors, angiectasias, erosions, ulcers, diverticula or active bleeding

    2 weeks

Secondary Outcomes (2)

  • Safety: number of participants with any procedure-related adverse events

    2 weeks

  • Patient's preference: number of participants preferring capsule endoscopy or colonoscopy

    2 weeks

Other Outcomes (3)

  • Quality of bowel preparation at capsule endoscopy (small bowel)

    2 weeks

  • Quality of bowel preparation at capsule endoscopy (colon)

    2 weeks

  • Quality of bowel preparation at colonoscopy

    2 weeks

Study Arms (2)

Pan-intestinal capsule endoscopy

EXPERIMENTAL

PillCam Crohn's capsule protocol

Diagnostic Test: Pan-intestinal capsule endoscopy

Conventional colonoscopy

ACTIVE COMPARATOR

Same-day colonoscopy under propofol sedation

Diagnostic Test: Pan-intestinal capsule endoscopy

Interventions

Patients with iron deficiency anemia or overt GI bleeding with non-diagnostic upper GI endoscopy will be submitted to same-day pan-intestinal capsule endoscopy using PillCam Crohn's Capsule (Medtronic) followed by conventional colonoscopy under propofol sedation

Also known as: Conventional colonoscopy
Conventional colonoscopyPan-intestinal capsule endoscopy

Eligibility Criteria

Age8 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients from external consultation, hospital ward or urgency department, with suspected GI bleeding presenting in the occult form as IDA (Hb \<12.0 g/dL in female gender or \<13.0 g/dL in male gender) and/or overt GI bleeding presenting as melaena and/or haematochezia, and with prior non-diagnostic upper GI endoscopy (esophagogastroduodenoscopy, EGD)

You may not qualify if:

  • Lack of informed consent
  • Suspected lesions at index EGD that could justify the anemia or digestive bleeding
  • Known history of gastroparesis or bowel dysmotility
  • Known or suspected intestinal stricture
  • Female patients with potential gynaecological source of bleeding causative of the clinical condition
  • Patients with severe malnutrition
  • Patients unable to walk at least for short periods and/or with neurological and/or psychiatric condition potentially favouring protocol deviations
  • Allergy or contra-indications to any of the drugs or products used in the study
  • Pregnancy or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gastroenterology Department, Hospital da Senhora da Oliveira

Guimarães, 4835-044, Portugal

Location

MeSH Terms

Conditions

Anemia, Iron-DeficiencyGastrointestinal Hemorrhage

Interventions

Endoscopy

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesGastrointestinal DiseasesDigestive System DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Bruno Rosa, MD

    Gastroenterology Department, Hospital da Senhora da Oliveira - Guimarães, Portugal

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Masking Details
The capsule endoscopy reader will be independent from the physicians performing the conventional colonoscopies, and all investigators will be blinded to each other's findings and reports. Capsule endoscopy and colonoscopy findings will be compared and in case of disagreement it will be discussed until a consensus is reached, if necessary, with the intervention of an independent third reader, experienced in both techniques and not involved in the primary reading of any of the examinations.
Purpose
DIAGNOSTIC
Intervention Model
FACTORIAL
Model Details: Prospective, single-blinded, single center cohort study. All patients will undergo pan-intestinal capsule endoscopy followed by conventional colonoscopy with deep sedation in the same day, with no need for further bowel preparation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 20, 2021

First Posted

March 4, 2021

Study Start

June 19, 2020

Primary Completion

September 20, 2022

Study Completion

January 31, 2023

Last Updated

September 22, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations